[ORGANIZATION]
Tagrisso
Featured in 2 tracked stories · first seen
Also covered in
-
Tagrisso shows 79% 8-year survival rate in EGFR-mutated lung cancer study
[HEALTH] · 2 sources ·
-
AstraZeneca beats Q2 forecasts as oncology sales rise, but Ultomiris misses late‑stage trial goal
[BUSINESS] · 30 sources ·